Violence, Domestic
Conditions
Keywords
Intimate Partner Violence
Brief summary
Intimate partner violence (IPV) against women in the US is a serious public health problem and a human rights issue. Our research team has developed confidential screening tools using exam-room computer for intimate partner violence to be used in primary care.
Detailed description
The objective of this study was to develop and evaluate an integrated suite of electronic health record (EHR) tools that automates best practices from Northern California Kaiser Permanente for screening and intervention for IPV identified within clinical settings. The goal of the intervention goes beyond mere screening of patients for IPV and includes tools for assessment of IPV risk, for documentation of IPV care, and support for a warm hand-off during the primary care visit to a national IPV hotline resource. Importantly, the study includes work to keep notes documenting IPV and billing for IPV care confidential, segmenting this care in a secure segment of the electronic health record.
Interventions
DIAGNOSTIC_TESTScreening for intimate partner violence
confidential screening using exam computer
OTHERAssessment and referral
confidential assessment and referral of high-risk patients using decision-support templates
Sponsors
Agency for Healthcare Research and Quality (AHRQ)
Medical University of South Carolina
Study design
Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
SCREENING
Masking
NONE
Intervention model description
This is a stepped wedge cluster randomized trial which has 3 sequences starting intervention in randomized order.
Eligibility
Sex/Gender
ALL
Age
18 Years to 49 Years
Healthy volunteers
No
Inclusion criteria
* Being an Medical University of South Carolina patient at primary care clinics (family medicine) * Women 18-49 years of age inclusive * Reported yes to wanting to be contacted for a follow-up research study * English-speaking
Exclusion criteria
* No
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| IPV positive (Yes/No) | 29 months | Depending on patient's answers to screening questions, they are flagged as either IPV positive or negative |
| Screening completed (Yes/No) | 29 months | Whether the assigned screening was completed during patient visit |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Severity of risk | 29 months | using Danger 5 risk assessment, ranging from 0 to 5 |
| Physician compliance with IPV management tools | 29 months | Measured as the rate of completion of follow-up decision templates, and the rate of referrals for post-visit counseling to a national hotline (a share from screened positive patients |
Countries
United States
Outcome results
None listed